Breaking News

You are here » Indian-Commodity  :  Investment  :  Adani Green Energy acquires 100% stake in AREPL

10-Aug2018

Adani Green Energy acquires 100% stake in AREPL

Adani Green Energy (AGEL) has acquired 100% equity share capital of Adani Renewable Energy Park (AREPL) from Adani Tradecom LLP and Adani Trading Services LLP on August 9, 2018. AREPL is acquired with an object of having the benefits of synergy.

The said Company was incorporated in March, 2015 for the purpose of undertaking the business of development of integrated renewable energy parks.

Adani Green Energy builds, owns and operates power plants powered by renewable sources of energy like solar and wind.


Related News

View all news

Ganesh Films acquires distribution rights for 'Ezhumin'

Ganesh Films India has acquired the sole theatrical distribution rights for North India region from Vaiyam Mediyas for Tamil language movie 'Ezhumin'. It is an upcoming Tamil language movie based on importance......

Reliance Industries' arm acquires stake in SkyTran

Reliance Industries' (RIL) wholly owned subsidiary -- Reliance Industrial Investments and Holdings has successfully acquired 12.7% shareholding (on fully diluted basis) in SkyTran Inc. (SkyTran), a US......

Manomay Tex India to avail credit facilities up to Rs 80.62 crore from Consortium Bank

Manomay Tex India has received an approval for availing Credit Facilities up to Rs 80.62 crore from Consortium Bank i.e. State Bank of India (Lead Bank), Industrial Estate Branch, Bhilwara and Oriental......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......